These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18304620)

  • 1. Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody.
    Oei AL; Sweep FC; Massuger LF; Olthaar AJ; Thomas CM
    Gynecol Oncol; 2008 May; 109(2):199-202. PubMed ID: 18304620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
    Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False elevation of serum CA-125 level caused by human anti-mouse antibodies.
    Bertholf RL; Johannsen L; Guy B
    Ann Clin Lab Sci; 2002; 32(4):414-8. PubMed ID: 12458896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
    Sabbatini P; Dupont J; Aghajanian C; Derosa F; Poynor E; Anderson S; Hensley M; Livingston P; Iasonos A; Spriggs D; McGuire W; Reinartz S; Schneider S; Grande C; Lele S; Rodabaugh K; Kepner J; Ferrone S; Odunsi K
    Clin Cancer Res; 2006 Sep; 12(18):5503-10. PubMed ID: 17000686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of idiotypic human anti-mouse antibody against in vitro binding and antitumor activity of a monoclonal antibody-drug conjugate.
    Otsuji E; Tsuruta H; Toma A; Kobayashi S; Okamoto K; Yata Y; Yamagishi H
    Hepatogastroenterology; 2003; 50(50):380-4. PubMed ID: 12749227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival.
    Oei AL; Verheijen RH; Seiden MV; Benigno BB; Lopes A; Soper JT; Epenetos AA; Massuger LF
    Int J Cancer; 2007 Jun; 120(12):2710-4. PubMed ID: 17354223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and clinical relevance of patient immune responses to intravenous therapy with murine monoclonal antibodies conjugated to adriamycin.
    Avner B; Swindell L; Sharp E; Liao SK; Ogden JR; Avner BP; Oldham RK
    Mol Biother; 1991 Mar; 3(1):14-21. PubMed ID: 2069755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of human anti-mouse antibody in serum by flow cytometry.
    Labus JM; Petersen BH
    Cytometry; 1992; 13(3):275-81. PubMed ID: 1576893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oregovomab maintenance monoimmunotherapy does not improve outcomes in advanced ovarian cancer.
    Berek J; Taylor P; McGuire W; Smith LM; Schultes B; Nicodemus CF
    J Clin Oncol; 2009 Jan; 27(3):418-25. PubMed ID: 19075271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1.
    Oei AL; Sweep FC; Geurts-Moespot A; van Tienoven D; Von Mensdorff-Pouilly S; Thomas CM; Massuger LF
    Anticancer Res; 2008; 28(5A):2721-5. PubMed ID: 19035301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA 125: fundamental and clinical aspects.
    Verheijen RH; von Mensdorff-Pouilly S; van Kamp GJ; Kenemans P
    Semin Cancer Biol; 1999 Apr; 9(2):117-24. PubMed ID: 10202133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased production of anti-mouse antibody after administration of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate to human.
    Yata Y; Otsuji E; Okamoto K; Tsuruta H; Kobayashi S; Toma A; Yamagishi H
    Hepatogastroenterology; 2003; 50(49):80-4. PubMed ID: 12629996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal cefazolin and ceftazidime effects on human peritoneal mesothelial cell release of cancer antigen-125.
    Manley HJ; Elwell RJ; Bailie GR; Welch CL
    Ann Pharmacother; 2004 Dec; 38(12):2035-40. PubMed ID: 15536141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of IgG and IgM human anti-mouse antibodies (HAMA) interference in CA 125 measurements using affinity chromatography.
    Koper NP; Thomas CM; Massuger LF; Segers MF; Olthaar AJ; Verbeek AL
    Clin Chem Lab Med; 1998 Jan; 36(1):23-8. PubMed ID: 9594082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical relevance of human anti-mouse-antibody (HAMA) in immunoscintigraphy].
    Hertel A; Baum RP; Auerbach B; Herrmann A; Hör G
    Nuklearmedizin; 1990 Nov; 29(5):221-7. PubMed ID: 2277773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human anti-mouse antibodies: pitfalls in tumor marker measurement and strategies for enhanced assay robustness; including results with Elecsys CEA.
    Nussbaum S; Roth HJ
    Anticancer Res; 2000; 20(6D):5249-52. PubMed ID: 11326704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-murine antibody response to mouse monoclonal antibodies in cancer patients.
    Sakahara H; Saga T; Onodera H; Yao Z; Nakamoto Y; Zhang M; Sato N; Nakada H; Yamashina I; Endo K; Konishi J
    Jpn J Cancer Res; 1997 Sep; 88(9):895-9. PubMed ID: 9369938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.